ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,024
Screening encounters
4,762
Diagnostic referrals
908
Outstanding pathways
324

Screening pathway

  1. Screening4,762Encounters
  2. Positive finding1,642Documented findings
  3. Referral908Diagnostic referrals
  4. Follow-up1,085Diagnostic visits
  5. Outcome584Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2437 · EXP-2437Synthetic · Site C

Full participant history through 2026-12-22, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-07-14
  4. · Diagnostic referral · EXP-2437-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Transport difficulty
  8. · Diagnostic visit · Missed
  9. · Diagnostic booking · Rebooking
  10. · Diagnostic visit · Missed
  11. · Screening · HPV DNA · Repeat · Prior VIA positive
  12. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2743 · Expanded synthetic participant 2743Site E — Resource-Constrained Navigation Programme
EXP-2745 · Expanded synthetic participant 2745Site A — Urban Referral Hub
EXP-2746 · Expanded synthetic participant 2746Site C — Rural Outreach Programme
EXP-2747 · Expanded synthetic participant 2747Site B — Peri-Urban Access Programme
EXP-2748 · Expanded synthetic participant 2748Site A — Urban Referral Hub
EXP-2749 · Expanded synthetic participant 2749Site B — Peri-Urban Access Programme
EXP-2750 · Expanded synthetic participant 2750Site D — Community Engagement Programme
EXP-2752 · Expanded synthetic participant 2752Site C — Rural Outreach Programme
EXP-2754 · Expanded synthetic participant 2754Site A — Urban Referral Hub
EXP-2755 · Expanded synthetic participant 2755Site B — Peri-Urban Access Programme
EXP-2756 · Expanded synthetic participant 2756Site B — Peri-Urban Access Programme
EXP-2757 · Expanded synthetic participant 2757Site A — Urban Referral Hub
EXP-2759 · Expanded synthetic participant 2759Site A — Urban Referral Hub
EXP-2760 · Expanded synthetic participant 2760Site A — Urban Referral Hub
EXP-2761 · Expanded synthetic participant 2761Site E — Resource-Constrained Navigation Programme
EXP-2763 · Expanded synthetic participant 2763Site B — Peri-Urban Access Programme
EXP-2766 · Expanded synthetic participant 2766Site B — Peri-Urban Access Programme
EXP-2767 · Expanded synthetic participant 2767Site B — Peri-Urban Access Programme
EXP-2768 · Expanded synthetic participant 2768Site D — Community Engagement Programme
EXP-2769 · Expanded synthetic participant 2769Site A — Urban Referral Hub
EXP-2770 · Expanded synthetic participant 2770Site C — Rural Outreach Programme
EXP-2771 · Expanded synthetic participant 2771Site B — Peri-Urban Access Programme
EXP-2772 · Expanded synthetic participant 2772Site E — Resource-Constrained Navigation Programme
EXP-2773 · Expanded synthetic participant 2773Site E — Resource-Constrained Navigation Programme
EXP-2775 · Expanded synthetic participant 2775Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1813
HPV DNA
2278
Cytology
671

Navigation activity

Barrier documented
812
Contact attempt
1334
Navigation intervention
351
Diagnostic booking
1134
Diagnostic visit
1085

Documented barriers

Contact difficulty
259
Transport difficulty
267
Appointment coordination
286

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.